Octave Specialty Group (OSG): Director received 4,524 units
Michael D Price, Director at Octave Specialty Group, reported a grant / award of 4,524 units.
- 4,524
- Derivative units
- Traded
- Jan 1, 2026
- Filed
- Jan 6, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 31, 2025Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 2 more items)“On October 31, 2025 , (the “ Closing Date ”), the Company and its wholly owned subsidiary, Cirrata VI, completed the previously announced acquisition of all of the issued and outstanding limited liability company interests of ArmadaCorp Capital, LLC, a wholly owned subsidiary of Sirius Acquisitions Holding Company (the “ArmadaCorp Acquisition”), pursuant to and upon the terms and subject to the conditions set forth…”
- Nov 10, 2025Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 12, 2025InsiderOfficer purchased ~$205 of OSG shares in the open market
- Dec 10, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“Change in Registrant’s Certifying Accountant (a) Dismissal of Previous Independent Registered Public Accounting Firm As a matter of good corporate governance, the Audit Committee of the Board of Directors (the “Audit Committee”) of Octave Specialty Group, Inc., formerly known as Ambac Financial Group, Inc., (the “Company”) has been taking a number of steps in consideration of a potential audit firm rotation.”
What came next
- Jan 2, 2026Insider · Bought outside the usual windowCEO purchased ~$91K of OSG shares in the open market
- Feb 23, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 1, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Octave Specialty Group
OQRO holds no insider, Congress, fund or contract record for Octave Specialty Group dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OSG page.
Other recent filings by Michael D Price, Director
- SEC Form 4 at Octave Specialty Group (OSG)May 14, 2025
- SEC Form 4 at Octave Specialty Group (OSG)May 14, 2025
The full history of Michael D Price, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Octave Specialty Group (OSG) insider traded, and how much?
Michael D Price, Director at Octave Specialty Group, reported a grant / award of 4,524 units. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Jan 1, 2026. Filed: Jan 6, 2026. That is 5 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean OSG stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Octave Specialty Group
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 4Jan 6, 2026
- SEC Form 4Nov 15, 2025
- SEC Form 13F-HRNov 14, 2025
- SEC Form 4Aug 11, 2025
- SEC Form 4May 15, 2025
Everything OQRO holds on this company is on its OSG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data